🔗 Share this article

A shadow economy for unlicensed slimming medications is propelled by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Experimental Drug Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to contact these accounts directly for supplier links, while also receiving discount codes.

Thriving Commerce on Social Networks

Separately, a flourishing trade exists on Telegram, where groups with thousands of participants share comparison photos, injection guides and claims of rapid British shipping. Vendors market the substance there before redirecting customers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Experts Express Concerns

However, doctors and chemists have warned that the sale of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals injecting products of uncertain source.

Some professionals said the demand for retatrutide could be connected to the rising price of licensed slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for human use under the British medical regulations.

Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still breach pharmaceutical, advertising, and consumer laws, risking penalties, legal action or prison.

Platform Reaction and Content Elimination

According to the social media company, the platform has taken down violative material and prohibited associated hashtags and query recommendations. The company said it was committed to keeping the service safe and investing in strengthening enforcement strategies.

Online Trading Operations

Research also found communities with up to nine thousand members marketing the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of users, populated with images of slimming results, glowing testimonials and step-by-step instructions for mixing or administering at home.

Within minutes of joining one group, a vendor shared contact information, where the majority of transactions take place. The vendor provided an guidebook and promised delivery within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about body mass, medical conditions or past usage.

Product Details and Costs

Inside these groups, posts display black plastic packages with postal service labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use injectors usually sold at £160 for 20 milligrams. When questioned how long a injector should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service stated it regularly moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering materials they cannot confirm. Although the research behind this drug is sound, these digital versions may not contain what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her staff has previously encountered individuals harmed by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Producer Position

A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a company experimental product not yet authorized … may subject patients to potentially serious health risks”.